Page last updated: 2024-11-07

metaraminol and Muscle Spasticity

metaraminol has been researched along with Muscle Spasticity in 1 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Muscle Spasticity: A form of muscle hypertonia associated with upper MOTOR NEURON DISEASE. Resistance to passive stretch of a spastic muscle results in minimal initial resistance (a free interval) followed by an incremental increase in muscle tone. Tone increases in proportion to the velocity of stretch. Spasticity is usually accompanied by HYPERREFLEXIA and variable degrees of MUSCLE WEAKNESS. (From Adams et al., Principles of Neurology, 6th ed, p54)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GERSON, IM1

Other Studies

1 other study available for metaraminol and Muscle Spasticity

ArticleYear
Aramine peripheral vaso spastic effects during therapy. A case report.
    Journal of the Germantown Hospital, 1962, Volume: 3

    Topics: Metaraminol; Muscle Spasticity; Peripheral Vascular Diseases; Sympathomimetics; Vascular Diseases

1962